|
Frequency distribution of blood examination data |
||
| Items |
||
|
|
||
| Variables |
Glucose |
HbA1c |
|
|
||
| PATIENT INFORMATION |
||
| Number of subjects |
485 |
155 |
| Sex |
||
| Female |
187 (38.6) |
54 (34.8) |
| Male |
298 (61.4) |
101 (65.2) |
| Age, years |
||
| 20–49 |
67 (13.8) |
20 (12.9) |
| 50–59 |
103 (21.2) |
33 (21.3) |
| 60–69 |
150 (31.0) |
47 (30.3) |
| 70< |
165 (34.0) |
55 (35.5) |
| Medication |
||
| candesartan cilexetil |
177 (36.5) |
51 (32.9) |
| losartan potassium |
78 (16.1) |
35 (22.6) |
| olmesartan medoxomil |
56 (11.5) |
21 (13.5) |
| telmisartan |
56 (11.5) |
18 (11.6) |
| valsartan |
118 (24.3) |
30 (19.4) |
| DATA INFORMATION |
||
| Number of examinations |
2464 |
457 |
| Treatment duration |
||
| 0 = "Baseline" |
733 (29.8) |
150 (32.8) |
| 1 = "~3 M" |
1068 (43.3) |
132 (28.9) |
| 2 = "3~6 M" |
377 (15.3) |
89 (19.5) |
| 3 = "6~12 M" |
286 (11.6) |
86 (18.8) |
|
Abbreviations: HbA1c, hemoglobin A1c. All data are count (percentage). | ||
Kitamura et al. Cardiovascular Diabetology 2007 6:26 doi:10.1186/1475-2840-6-26 |
||